Shares of Limerick, Pa.-based medical device maker Teleflex (NYSE:TFX) held steady today after the company posted a modest dip in profits amid a strong boost in sales for its 2nd quarter 2013.
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
ConforMIS raises $168M Series E round
ConforMIS closed a Series E round worth $167.7 million, raised from a consortium of 88 unnamed investors, according to regulatory filings.
The Bedford, Mass.-based medical device company makes personalized knee implants based on scans detailing patients’ physiology, creating customized instruments and implants that are shipped in a sterile package surgeons can open on the operating table.
Reached by MassDevice.com today, CEO Philipp Lang declined to comment on the company’s latest funding round.
NeuWave Medical zeros in on $19M in equity financing
Wisconsin medical device maker NeuWave Medical is more than halfway to wrapping up a hoped-for $19 million equity funding round, with $14 million in the bank so far and 22 accredited investors, according to an SEC filing.
The new filing offered more details on a fundraising round that began almost 1 year ago. As of yesterday, the ablation device company has about $5 million left to go to top off the fund-raise.
Hansen Medical pulls in $93M, shares surge 20% | Wall Street Beat
Hansen Medical (NSDQ:HNSN) said it inked an equity financing deal for up to $93 million with a consortium of investors including Oracle Investment Management and private equity player Jack Schuler, a co-founder of Crabtree Partners.
Diabetes: GI Dynamics pulls in $35M tranche in $52M round
GI Dynamics (ASX:GID) said it’s pulled in nearly $35 million as part of a $52 million funding round it’s planning to use to back a U.S. trial of its EndoBarrier device.
The Lexington, Mass.-based medical device company said in a regulatory filing that it’s drummed up $34.8 million from 13 unnamed investors.
Allergan’s Q2 sales, profits rise
Allergan (NYSE:AGN) shares ticked up today on strong 2nd-quarter sales and earnings numbers, including a 7.4% top-line gain for its medical device segment.
Irvine, Calif.-based Allergan reported profits of $359.9 million, or $1.17 per share, on sales of $1.60 billion for the 3 months ended June 30, for bottom-line growth of 21.8% on sales growth of 10.2%.
Mako Surgical surges on strong Q2 numbers
Mako Surgical (NSDQ:MAKO) shares are up nearly 16% so far this morning after the medical device company reported 2nd-quarter numbers that shattered expectations on Wall Street.
NuVasive swings to Q2 red as it reveals OIG probe
Drama at Siemens: Rumors fly that outgoing CEO is looking to take chairman down with him
Sorin puts 2012 earthquake behind with 92% Q2 profit growth
Sorin Group (BIT:SRN) said it’s finally put the impact of a devastating earthquake behind it, reporting surging profit growth and a return to normal operations for the Italian plant hit by the temblor.
KCI to drop $485M on wound care company Systagenix
Kinetic Concepts Inc. said it agreed to acquire 1 of its private wound-care peers, Systagenix, for $485 million.
San Antonio, Texas-based KCI said the deal brings a large suite of complementary advanced wound care products into its portfolio.